CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Antibiotic, Pain and Scar

Bacitracin,Neomycin,Polymxin, Pramoxine· ingredient bacitracinAnesthetics for topical use· BACITRACIN 500 [USP'U]/100g; NEOMYCIN SULFATE 3.5 mg/100g; BACITRACIN ZINC 500 [iU]/g; NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 500 [USP'U]/1000mg; NEOMYCIN SULFATE 3.5 mg/1000mg; BACITRACIN ZINC 500 [USP'U]/100g; NEOMYCIN SULFATE 3.5 mg/100g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.12768
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other bacitracin products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.